KIMBERLY TOBIN: Open Payments
NPI 1104192699 · COLLEGEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,837 in 83 payments from 19 companies in 2025. Trend: 2023 $801 · 2024 $1,204 · 2025 $1,837
Food & beverage: $1,837
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $263 |
| ABBVIE INC. | 15 | $252 |
| AstraZeneca Pharmaceuticals LP | 12 | $219 |
| Lilly USA, LLC | 8 | $157 |
| GlaxoSmithKline, LLC. | 7 | $140 |
| Novo Nordisk Inc | 7 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $139 |
| Abbott Laboratories | 4 | $89 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| Novartis Pharmaceuticals Corporation | 3 | $69 |
Products named: NURTEC ODT, VRAYLAR, Kerendia, AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, XIFAXAN.
Industry payments across PA — which companies pay providers there.
